Aytu BioPharma Inc (LTS:0A8M)
$ 1.59 -0.01 (-0.62%) Market Cap: 9.90 Mil Enterprise Value: 6.35 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 40/100

Aytu Biopharma Inc Annual Shareholders Meeting Transcript

May 21, 2021 / 04:00PM GMT
Release Date Price: $112.04 (+2.41%)
Joshua R. Disbrow
Aytu Biopharma, Inc. - Chairman & CEO

Good morning. I'm Josh Disbrow, Chairman and CEO of to Aytu Biopharma, Inc., and it's a pleasure to welcome you to this Annual Meeting of shareholders. The meeting will come to order. The business before this meeting is described in our notice of annual meeting of stockholders and proxy statement, a copy of which has been mailed to our stockholders. This meeting is being held in accordance with Aytu's bylaws and Delaware law. A copy of the agenda and rules of conduct for the meeting has been provided through the web portal. It is our intention to conduct this meeting in accordance with these documents.

There will be an opportunity for questions about the proposals prior to voting. Please adhere to the rules of conduct attached to your agenda in addressing this meeting in connection with the proposals. If you have sent in a proxy, your vote will be counted automatically without any further action on your part. If you are eligible to vote and have not submitted your proxy or if you want to change your vote, please click on the stockholder

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot